Terns Pharmaceuticals to Participate in Upcoming Investor Conferences
- None.
- None.
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity, today announced that members of management will be participating in the following upcoming investor conferences:
H.C. Wainwright 7th Annual NASH Virtual Investor Conference
Date/Time: Tuesday, October 24, 2023 at 2:30 PM ET
Format: Fireside Chat
Location: Virtual
UBS Biopharma Conference
Date/Time: Wednesday, November 8, 2023 at 4:30 PM ET
Format: Fireside Chat
Location: Miami Beach, FL
Live webcasts of the fireside chats will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentations.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, NASH and obesity. Terns’ pipeline includes two clinical stage development programs including an allosteric BCR-ABL inhibitor and a THR-β agonist, and preclinical small-molecule GLP-1 receptor agonist and GIPR modulator programs. For more information, please visit: www.ternspharma.com.
Contacts for Terns
Investors
Justin Ng
investors@ternspharma.com
Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com
FAQ
What conferences will Terns Pharmaceuticals be participating in?
When will the conferences take place?
Where will the conferences be held?
Will there be webcasts of the fireside chats?
Will there be replays of the webcasts?
